Skip to main content

Table 2 Histopathological criteria of bronchogenic carcinoma

From: Bronchogenic carcinoma: the added value of FDG PET/CT advanced volumetric and metabolic parameters in initial evaluation and their impact on prognosis and clinical outcome

  

N

%

Side

Right

28

73.7

 

Left

12

26.3

Site

Upper lobe

32

78.9

 

Lower lobe

6

15.8

 

Middle lobe

2

5.3

Histopathological grade

Grade 2

18

47.4

 

Grade 3

8

15.8

 

Grade 4

14

36.8

Histopathology

Adenocarcinoma

32

84.2

 

Squamous cell carcinoma

4

10.6

 

Large cell carcinoma

2

5.2

 

Small cell carcinoma

2

5.2

T staging

T1

2

5.2

 

T2

12

31.6

 

T3

10

26.3

 

T4

16

36.8

N staging

N0

18

47.4

 

N2

14

31.6

 

N3

8

21.1

M staging

M0

24

57.9

 

M1

16

42.1

Pathological stage

1a3

12

31.6

 

3a

10

26.3

 

4b

16

42.1

Grade (cell diff)

Low (well differentiated)

10

21.1

 

Intermediate (moderately differentiated)

4

10.5

 

High (poorly differentiated)

26

68.4